11-105887378-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_000829.4(GRIA4):c.673-141G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000247 in 486,596 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000013 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000030 ( 0 hom. )
Consequence
GRIA4
NM_000829.4 intron
NM_000829.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.857
Publications
5 publications found
Genes affected
GRIA4 (HGNC:4574): (glutamate ionotropic receptor AMPA type subunit 4) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing of this gene results in transcript variants encoding different isoforms, which may vary in their signal transduction properties. Some haplotypes of this gene show a positive association with schizophrenia. [provided by RefSeq, Jul 2008]
GRIA4 Gene-Disease associations (from GenCC):
- neurodevelopmental disorder with or without seizures and gait abnormalitiesInheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Illumina, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0000299 (10/334846) while in subpopulation SAS AF = 0.000213 (5/23516). AF 95% confidence interval is 0.0000835. There are 0 homozygotes in GnomAdExome4. There are 7 alleles in the male GnomAdExome4 subpopulation. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 10 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRIA4 | NM_000829.4 | c.673-141G>T | intron_variant | Intron 5 of 16 | ENST00000282499.10 | NP_000820.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GRIA4 | ENST00000282499.10 | c.673-141G>T | intron_variant | Intron 5 of 16 | 5 | NM_000829.4 | ENSP00000282499.5 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151750Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2
AN:
151750
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000299 AC: 10AN: 334846Hom.: 0 AF XY: 0.0000394 AC XY: 7AN XY: 177668 show subpopulations
GnomAD4 exome
AF:
AC:
10
AN:
334846
Hom.:
AF XY:
AC XY:
7
AN XY:
177668
show subpopulations
African (AFR)
AF:
AC:
0
AN:
8010
American (AMR)
AF:
AC:
0
AN:
8946
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
10596
East Asian (EAS)
AF:
AC:
0
AN:
23338
South Asian (SAS)
AF:
AC:
5
AN:
23516
European-Finnish (FIN)
AF:
AC:
0
AN:
30808
Middle Eastern (MID)
AF:
AC:
0
AN:
1544
European-Non Finnish (NFE)
AF:
AC:
4
AN:
208102
Other (OTH)
AF:
AC:
1
AN:
19986
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151750Hom.: 1 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74100 show subpopulations
GnomAD4 genome
AF:
AC:
2
AN:
151750
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74100
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41324
American (AMR)
AF:
AC:
0
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5180
South Asian (SAS)
AF:
AC:
2
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10504
Middle Eastern (MID)
AF:
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67880
Other (OTH)
AF:
AC:
0
AN:
2088
Age Distribution
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.